You can still register onsite!

The 21st Annual

Perspectives in Urology: Point-Counterpoint

Will be held November 8 – 10, 2012

Advance registration ends at 5pm on November 1st; onsite registration begins at 10am on November 8th.

This meeting will be held at the
InterContinental Montelucia, Scottsdale, Arizona
Visit Hotel Website

Program Overview/Statement of Need

This activity is intended to educate urologists, oncologists, and other health care professionals involved in the diagnosis and management of urological diseases. It is particularly suited for those preparing for board (re)certification exams. The goal of this program is to enhance understanding of the evolving concepts in the current and future treatment strategies of this specialty to ensure the highest standard of patient care and safety.

Target Audience

This activity is designed for and will benefit urologists, urologic oncologists, medical oncologists, radiation oncologists, and other health care professionals involved in the diagnosis and management of urologic diseases.

Behavioral Learning Objectives/Anticipated Outcomes

At the conclusion of the activity, participants should be able to:

• Implement optimal practices for screening and treating prostate cancer, including the role of novel and experimental therapies.
• Summarize the most current information about the treatment of low-risk cancer, including the use of robotic versus laparoscopic approaches.
• Review new practice guidelines for the diagnosis and management of BPH and LUTS.
• Summarize vascular issues associated with nephrolithiasis and understand how to manage complications with percutaneous nephrolithotomy.
• Review new practice guidelines for the diagnosis and management of interstitial cystitis/bladder pain syndrome, a component of the continuum of painful vs. non-painful overactive bladder syndrome.
• Utilize optimal treatment for other urological diseases in males, including low testosterone, erectile dysfunctions, and testis cancer.
• Assess the appropriate use of emerging imaging, measurement, and surgical approaches in the treatment of renal cell carcinoma.

Continuing Education Credit

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The University of Colorado School of Medicine and Grant/Downing. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Tuition

Online registration for 2012 is now closed. On-site registration will begin at 10am on Thurs, Nov 8th

Rates are determined by the following schedule:

• Earlybird Registration – Must register by August 6:  $550
• Discounted Registration – Must register by October 15:  $600
• Regular Registration – After October 15:  $650
• Fellows, Residents, Students & Allied Health Professionals:  $350

If your registration must be canceled and your request is received in writing by 5pm MST October 1, 2012, your paid tuition, less a $75 administrative fee, will be refunded. No refunds will be granted after October 1, 2012.